Patient-level pooled analysis of adjudicated gastrointestinal outcomes in celecoxib clinical trials: meta-analysis of 51,000 patients enrolled in 52 randomized trials

Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies

(2011) Patricia McGettigan et al.   PLOS MEDICINE

NSAID-induced gastrointestinal and cardiovascular injury

(2010) Siew C Ng et al.   CURRENT OPINION IN GASTROENTEROLOGY

Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial

(2010) Francis KL Chan et al.   LANCET

Responder analysis for pain relief and numbers needed to treat in a meta-analysis of etoricoxib osteoarthritis trials: bridging a gap between clinical trials and clinical practice

(2009) R A Moore et al.   ANNALS OF THE RHEUMATIC DISEASES

Nonsteroidal Anti-Inflammatory Drugs and Lower Gastrointestinal Complications

(2009) Angel Lanas et al.   GASTROENTEROLOGY CLINICS OF NORTH AMERICA

A Novel Composite Endpoint to Evaluate the Gastrointestinal (GI) Effects of Nonsteroidal Antiinflammatory Drugs Through the Entire GI Tract

(2009) F. K. L. CHAN et al.   JOURNAL OF RHEUMATOLOGY

Risk of Upper Gastrointestinal Complications Associated with Cyclooxygenase-2 Selective and Nonselective Nonsteroidal Antiinflammatory Drugs

(2009) Jordi Castellsague et al.   PHARMACOTHERAPY

Subgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groups

(2008) Daniel H. Solomon et al.   ARTHRITIS AND RHEUMATISM